This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bravo, E. L. Articles by Tagle, R. Search for Related Content PubMed PubMed Citation Articles by Bravo, E. L. Articles by Tagle, R.

Pheochromocytoma: State-of-the-Art and Future Prospects

Department of Nephrology and Hypertension, Cleveland Clinic Foundation, Cleveland Ohio 44195

Correspondence: Address all correspondence and requests for reprints to: Emmanuel L. Bravo, M.D., Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk A51, Cleveland, Ohio 44195. E-mail: bronofs{at}ccf.org

This review provides current understanding of the pathophysiology of pheochromocytoma and the wide range of associated clinical manifestations that have led to earlier recognition of the disease. In addition, it reviews optimal screening methods and localization techniques that have enhanced the clinician’s ability to make the diagnosis with greater certainty. This article will also discuss alternative antihypertensive regimens and innovative anesthetic and surgical procedures that have made successful management more promising than ever before.

Areas requiring further development include additional clinical experience with the measurement of plasma metanephrines that have been shown to have high sensitivity and specificity in the diagnosis of sporadic and familial pheochromocytoma, optimizing cost effectiveness of diagnostic imaging, improving the ability to predict and treat malignant pheochromocytoma, and elucidating not only the surgical approach but, perhaps with rapid advances in molecular genetics, ways of preventing familial pheochromocytoma.

This article has been cited by other articles:

				H. Bruynzeel, R. A. Feelders, T. H. N. Groenland, A. H. van den Meiracker, C. H. J. van Eijck, J. F. Lange, W. W. de Herder, and G. Kazemier Risk Factors for Hemodynamic Instability during Surgery for Pheochromocytoma J. Clin. Endocrinol. Metab., February 1, 2010; 95(2): 678 - 685. [Abstract] [Full Text] [PDF]

				J. W. M. Lenders, K. Pacak, T.-T. Huynh, Y. Sharabi, M. Mannelli, G. Bratslavsky, D. S. Goldstein, S. R. Bornstein, and G. Eisenhofer Low Sensitivity of Glucagon Provocative Testing for Diagnosis of Pheochromocytoma J. Clin. Endocrinol. Metab., January 1, 2010; 95(1): 238 - 245. [Abstract] [Full Text] [PDF]

				M. E BERRY Adrenal Gland Disorders Radiol. Technol., September 1, 2009; 81(1): 57 - 73. [Abstract] [Full Text] [PDF]

				K. Nomura, H. Kimura, S. Shimizu, H. Kodama, T. Okamoto, T. Obara, and K. Takano Survival of Patients with Metastatic Malignant Pheochromocytoma and Efficacy of Combined Cyclophosphamide, Vincristine, and Dacarbazine Chemotherapy J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 2850 - 2856. [Abstract] [Full Text] [PDF]

				H. R. Mobine, A. B. Baker, L. Wang, H. Wakimoto, K. C. Jacobsen, C. E. Seidman, J.G. Seidman, and E. R. Edelman Pheochromocytoma-Induced Cardiomyopathy is Modulated by the Synergistic Effects of Cell-Secreted Factors Circ Heart Fail, March 1, 2009; 2(2): 121 - 128. [Abstract] [Full Text] [PDF]

				S. Grozinsky-Glasberg, I. Shimon, M. Korbonits, and A. B Grossman Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms Endocr. Relat. Cancer, September 1, 2008; 15(3): 701 - 720. [Abstract] [Full Text] [PDF]

				J. T. Adler, G. Y. Meyer-Rochow, H. Chen, D. E. Benn, B. G. Robinson, R. S. Sippel, and S. B. Sidhu Pheochromocytoma: Current Approaches and Future Directions Oncologist, July 1, 2008; 13(7): 779 - 793. [Abstract] [Full Text] [PDF]

				R. T Peaston and S. Ball Biochemical detection of phaeochromocytoma: why are we continuing to ignore the evidence? Ann Clin Biochem, January 1, 2008; 45(1): 6 - 10. [Abstract] [Full Text] [PDF]

				A. Karagiannis, D. P Mikhailidis, V. G Athyros, and F. Harsoulis Pheochromocytoma: an update on genetics and management Endocr. Relat. Cancer, December 1, 2007; 14(4): 935 - 956. [Abstract] [Full Text] [PDF]

				H. J.L.M. Timmers, J. A. Carrasquillo, M. Whatley, G. Eisenhofer, C. C. Chen, A. Ling, W. M. Linehan, P. A. Pinto, K. T. Adams, and K. Pacak Usefulness of Standardized Uptake Values for Distinguishing Adrenal Glands with Pheochromocytoma from Normal Adrenal Glands by Use of 6-18F-Fluorodopamine PET J. Nucl. Med., December 1, 2007; 48(12): 1940 - 1944. [Abstract] [Full Text] [PDF]

				K. Pacak Preoperative Management of the Pheochromocytoma Patient J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4069 - 4079. [Abstract] [Full Text] [PDF]

				A. Chrisoulidou, G. Kaltsas, I. Ilias, and A. B Grossman The diagnosis and management of malignant phaeochromocytoma and paraganglioma Endocr. Relat. Cancer, September 1, 2007; 14(3): 569 - 585. [Abstract] [Full Text] [PDF]

				I. Ilias, A. Sahdev, R. H Reznek, A. B Grossman, and K. Pacak The optimal imaging of adrenal tumours: a comparison of different methods Endocr. Relat. Cancer, September 1, 2007; 14(3): 587 - 599. [Abstract] [Full Text] [PDF]

				M. d'Herbomez, G. Forzy, C. Bauters, C. Tierny, P. Pigny, B. Carnaille, F. Pattou, J.-L. Wemeau, and N. Rouaix An analysis of the biochemical diagnosis of 66 pheochromocytomas Eur. J. Endocrinol., May 1, 2007; 156(5): 569 - 575. [Abstract] [Full Text] [PDF]

				P. Kaji, J. A Carrasquillo, W M. Linehan, C. C Chen, G. Eisenhofer, P. A Pinto, E. W Lai, and K. Pacak The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome Eur. J. Endocrinol., April 1, 2007; 156(4): 483 - 487. [Abstract] [Full Text] [PDF]

				G. W. Colby, K. P. Banks, and E. Torres AJR teaching file: Incidental adrenal mass and hypertension. Am. J. Roentgenol., September 1, 2006; 187(3 Suppl): S470 - S472. [Full Text] [PDF]

				L. Amar, J. Bertherat, E. Baudin, C. Ajzenberg, B. Bressac-de Paillerets, O. Chabre, B. Chamontin, B. Delemer, S. Giraud, A. Murat, et al. Genetic Testing in Pheochromocytoma or Functional Paraganglioma J. Clin. Oncol., December 1, 2005; 23(34): 8812 - 8818. [Abstract] [Full Text] [PDF]

				L. Amar, A. Servais, A.-P. Gimenez-Roqueplo, F. Zinzindohoue, G. Chatellier, and P.-F. Plouin Year of Diagnosis, Features at Presentation, and Risk of Recurrence in Patients with Pheochromocytoma or Secreting Paraganglioma J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2110 - 2116. [Abstract] [Full Text] [PDF]

				W H van Houtum, E P M Corssmit, P B Douwes Dekker, J C Jansen, A G L van der Mey, A H J T Brocker-Vriends, P E M Taschner, M Losekoot, M Frolich, M P M Stokkel, et al. Increased prevalence of catecholamine excess and phaeochromocytomas in a well-defined Dutch population with SDHD-linked head and neck paragangliomas Eur. J. Endocrinol., January 1, 2005; 152(1): 87 - 94. [Abstract] [Full Text] [PDF]

				E. C. Heider, B. G. Davis, and E. L. Frank Nonparametric Determination of Reference Intervals for Plasma Metanephrine and Normetanephrine Clin. Chem., December 1, 2004; 50(12): 2381 - 2384. [Full Text] [PDF]

				G. A. Kaltsas, G. M. Besser, and A. B. Grossman The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors Endocr. Rev., June 1, 2004; 25(3): 458 - 511. [Abstract] [Full Text] [PDF]

				I. Ilias and K. Pacak Current Approaches and Recommended Algorithm for the Diagnostic Localization of Pheochromocytoma J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 479 - 491. [Full Text] [PDF]